Squarepoint Ops LLC V Tv Therapeutics Inc. Transaction History

Squarepoint Ops LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$1.53 - $2.22 $44,037 - $63,898	-28,783 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$2.27 - $3.44 $65,337 - $99,013	28,783 New	28,783 $66,000
Q1 2021 May 17, 2021	SELL	$1.97 - $2.89 $64,655 - $94,849	-32,820 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$1.49 - $3.1 $144 - $300	-97 Reduced 0.29%	32,820 $61,000
Q3 2020 Nov 16, 2020	SELL	$1.7 - $2.98 $45,420 - $79,619	-26,718 Reduced 44.8%	32,917 $58,000

Q2 2020 Aug 14, 2020	BUY	$1.74 - $3.19 $103,764 - $190,235	59,635 New	59,635 $134,000

243K

Ticker VTVT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 81,483,600
Market Cap $1.49B
Description
vTv Therapeutics Inc., a clinical-stage biopharmaceutical company, focuses on the development of orally administered treatments for diabetes. The company is developing TTP399, an orally administered, small molecule, and liver-selective glucokinase activator for the treatment of type 1 diabetes; and HPP737, an orally administered non-CNS penetran...

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

Stay updated on Squarepoint Ops LLC with notifications on news.